CARMEN DUNBAR: Open Payments
NPI 1144986951 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 46 payments from 15 companies in 2025. Trend: 2023 $824 · 2024 $502 · 2025 $1,103
Food & beverage: $1,013Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $240 |
| JAZZ PHARMACEUTICALS INC. | 8 | $211 |
| LivaNova USA, Inc. | 1 | $129 |
| Teva Pharmaceuticals USA, Inc. | 4 | $121 |
| Neurocrine BioSciences, Inc. | 5 | $100 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| ACADIA Pharmaceuticals Inc | 2 | $47 |
| Biogen, Inc. | 2 | $40 |
| Genentech USA, Inc. | 1 | $26 |
| Eisai Inc. | 1 | $26 |
Products named: VYALEV, XYWAV, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, AUSTEDO XR, INGREZZA, NUPLAZID, LEQEMBI, Sunosi.
Industry payments across TX — which companies pay providers there.
